Nov. 23, 2021
Salem – The Oregon Department of Consumer and Business Services will be hosting a public hearing on prescription drug prices on Wednesday, Dec. 8, from 1 to 3 p.m. via Zoom.
Oregonians are encouraged to participate in two ways.
The Prescription Drug Price Transparency Act (ORS 646A.689) directed the Oregon Department of Consumer and Business Services to establish a transparency program to accept reports and disclose certain information from prescription drug manufacturers, health insurance carriers, and consumers on drug prices.
The goal of the program is to provide accountability for prescription drug pricing through the notice and disclosure of specific drug costs and price information from pharmaceutical manufacturers, health insurers, and consumers.
###
The Division of Financial Regulation is part of the Department of Consumer and Business Services, Oregon’s largest business regulatory and consumer protection agency. Visit dfr.oregon.gov and dcbs.oregon.gov.